Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    PANCREATIC GS 6624 MARYLAND
Show Display Options
Download search resultsDownload the search results for:
PANCREATIC GS 6624 MARYLAND (1 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Condition: Pancreatic Cancer
Interventions: Drug: Simtuzumab;   Drug: Gemcitabine;   Drug: Placebo to match simtuzumab

Study has passed its completion date and status has not been verified in more than two years.